Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

May 14, 2024

BUY
$0.85 - $1.41 $65,416 - $108,513
76,960 New
76,960 $72,000
Q2 2022

Aug 15, 2022

SELL
$0.85 - $1.41 $48,723 - $80,824
-57,322 Reduced 42.69%
76,960 $72,000
Q1 2022

May 16, 2022

SELL
$1.16 - $2.5 $328,763 - $708,542
-283,417 Reduced 67.85%
134,282 $178,000
Q4 2021

Feb 14, 2022

BUY
$2.46 - $8.74 $654,332 - $2.32 Million
265,989 Added 175.33%
417,699 $1.03 Million
Q3 2021

Nov 10, 2021

BUY
$5.1 - $9.39 $773,721 - $1.42 Million
151,710 New
151,710 $1.3 Million

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.